EUVIMEDEUVIMED entdecken
Crossref

Targeting MAPK14 in microglial cells: neuroimmune implications of Panax ginseng in post-stroke inflammation

Hongxu Guan iD, Xiaoting Yang iD, Mingfeng Yang iD, Haitao Wang iD

Journal of Pharmacy and Pharmacology · 2025

DOI: 10.1093/jpp/rgae067 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, 2025. Verfasst von Hongxu Guan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Second Affiliated Hospital, Shandong First Medical University, Tai'an 271000, China. Hauptthemen laut MEDLINE: Microglia, Panax, Ginsenosides. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 71 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

This study investigates the molecular mechanisms through which Panax ginseng and Panax notoginseng saponin (PNS) mitigate neuroinflammatory damage and promote neural repair postischemic stroke, utilizing bioinformatics, and experimental approaches.

Background

Cerebral infarction significantly contributes to disability worldwide, with chronic neuroinflammation worsening cognitive impairments and leading to neurodegenerative diseases. Addressing neuroimmune interactions is crucial for slowing disease progression and enhancing patient recovery, highlighting the need for advanced research in neuroimmune regulatory mechanisms and therapeutic strategies.

Objective

To elucidate the effects of the traditional Chinese medicine components Panax ginseng and PNS on neuroinflammatory damage following ischemic stroke, focusing on the molecular pathways involved in mitigating inflammation and facilitating neural repair.

Methods

The study employs single-cell sequencing and transcriptomic analysis to investigate gene expression changes associated with cerebral infarction. Gene set enrichment analysis and weighted gene co-expression network analysis are used to identify key molecular markers and core genes. Furthermore, pharmacological profiling, including functional assays, assesses the impact of Ginsenoside-Rc, a PNS derivative, on microglial cell viability, cytokine production, and reactive oxygen species (ROS) levels.

Results

Our analysis revealed that MAPK14 is a critical mediator in the neuroinflammatory response to ischemic stroke. Ginsenoside-Rc potentially targets and modulates MAPK14 activity to suppress inflammation. Experimental validation showed that Ginsenoside-Rc treatment, combined with MAPK14 silencing, significantly alters MAPK14 expression and mitigates neuroinflammatory damage, evidenced by reduced microglial cell death, inflammatory factor secretion, and ROS production.

Conclusion

Ginsenoside-Rc’s modulation of MAPK14 offers a promising therapeutic strategy for reducing neuroinflammation and potentially improving cognitive recovery post-ischemic stroke. This supports the therapeutic application of the traditional Chinese medicine Sanqi in ischemic stroke care, providing a theoretical and experimental foundation for its use. Others Future work will focus on extending these findings through clinical trials to evaluate the efficacy and safety of Ginsenoside-Rc in human subjects, aiming to translate these promising preclinical results into practical therapeutic interventions for ischemic stroke recovery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicrogliaPanaxGinsenosidesAnimalsNeuroinflammatory DiseasesReactive Oxygen SpeciesInflammationMiceStrokePanax notoginsengIschemic StrokeMice, Inbred C57BLCytokinesCell SurvivalHumansSaponins

Stichwörter der Autor:innen

Panax ginsengMAPK14cerebral infarctionneuroinflammationsingle-cell sequencingtranscriptomic analysis

Substanzen

GinsenosidesReactive Oxygen SpeciesCytokinesSaponins

Autor:innen und Institutionen

  • Department of Neurology, Second Affiliated Hospital, Shandong First Medical University, Tai'an 271000, China.
  • Taishan Nursing Vocational College, Tai'an 271000, China.
  • Key Laboratory of Cerebral Microcirculation in Shandong First Medical University, Tai'an, Shandong 271000, China.

ORCID-Profile: Hongxu Guan, Xiaoting Yang, Mingfeng Yang, Haitao Wang

Zitieren

APA

Guan, H., Yang, X., Yang, M., & Wang, H. (2025). Targeting MAPK14 in microglial cells: neuroimmune implications of Panax ginseng in post-stroke inflammation. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgae067

Vancouver

Guan H, Yang X, Yang M, Wang H. Targeting MAPK14 in microglial cells: neuroimmune implications of Panax ginseng in post-stroke inflammation. Journal of Pharmacy and Pharmacology. 2025. doi:10.1093/jpp/rgae067

BibTeX
@article{Guan2025,
  author = {Guan, Hongxu and Yang, Xiaoting and Yang, Mingfeng and Wang, Haitao},
  title = {Targeting MAPK14 in microglial cells: neuroimmune implications of Panax ginseng in post-stroke inflammation},
  journal = {Journal of Pharmacy and Pharmacology},
  year = {2025},
  doi = {10.1093/jpp/rgae067}
}
Kostenlos starten →